Potent CD4+ T-cell epitope P30 enhances HER2/neu-engineered dendritic cell-induced immunity against Tg1-1 breast cancer in transgenic FVBneuN mice by enhanced CD4+ T-cell-stimulated CTL responses
Yufeng Xie(Fudan University), J Xiang(University of Saskatchewan), Amer Sami(University of Saskatchewan), Shahid Ahmed(Emory University), Khawaja Ashfaque Ahmed(University of Saskatchewan), Y Chen, Rajni Chibbar(Royal University Hospital), Min Tao(Tongji Hospital), Xiaoying Tang(Beijing Institute of Technology), W Li(University of Saskatchewan), Jianqing Xu(Weifang Medical University)
Cited by 17
Related Papers
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
|Cancers|2023|640
Gallbladder Cancer in the 21st Century
|Journal of Oncology|2015|301
Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection
|Proceedings of the National Academy of Sciences|2013|287
Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8+ T cells
|Nature Communications|2015|276
Near-Infrared-Absorbing B–N Lewis Pair-Functionalized Anthracenes: Electronic Structure Tuning, Conformational Isomerism, and Applications in Photothermal Cancer Therapy
|Journal of the American Chemical Society|2022|274